R. Bellante

IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study

P. De Cata, F. Turchi, G. Di Giovanni, 2022, Diabetes Therapy.

Dapagliflozin acutely improves Kidney Function in Type 2 Diabetes Mellitus. The PRECARE Study.

C. Gazzaruso, P. Fiorina, F. Folli, 2022, Pharmacological research.

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

J. Bonventre, G. Zuccotti, R. Abdi, 2020, Diabetes Care.

Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control

R. Trevisan, A. Dodesini, G. Lepore, 2022, Acta Diabetologica.